10499-15-7

Basic information

• Product Name: 7-benzyloxy-3-(4-methoxyphenyl)-3H-benzopyran-4-one
• Synonyms: 7-benzyloxy-3-(4-methoxyphenyl)-3H-benzopyran-4-one
• CAS NO: 10499-15-7
• Molecular Weight: 360.409
• Mol File: 10499-15-7.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 7-benzyloxy-3-(4-methoxyphenyl)-3H-benzopyran-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: 7-benzyloxy-3-(4-methoxyphenyl)-3H-benzopyran-4-one(10499-15-7)
• EPA Substance Registry System: 7-benzyloxy-3-(4-methoxyphenyl)-3H-benzopyran-4-one(10499-15-7)

Safety Data

• Hazardous Substances Data: 10499-15-7(Hazardous Substances Data)

Upstream product

• 100-44-7 benzyl chloride 
• 487-49-0 1-(2,4-dihydroxyphenyl)-2-(4-methoxyphenyl)ethanone 
• 108-46-3 recorcinol 
• 50-00-0 formaldehyd 
• 95307-71-4 1-[2-hydroxy-4-(phenylmethoxy)phenyl]-2-(4-methoxyphenyl)ethanone 
• 51-80-9 bis-(dimethylamino)methane 
• 104-01-8 4-Methoxyphenylacetic acid 

Downstream Products

• 10499-17-9 3,4-dihydro-7-hydroxy-3-(4-methoxyphenyl)-2H-1-benzopyran 
• 955950-58-0 4-[3-(4-methoxyphenyl)-chroman-7-yloxy]butyric acid ethyl ester 
• 4626-22-6 Dihydroformononetin 

Relevant articles and documents

In vivo evaluation of substituted 3-phenyl,7-methoxy-benzopyrans as modified estrogens

Substituted 3-phenyl,7-methoxy-benzopyran derivatives and vitamin D 3 (cholecalciferol, 1) were evaluated for their estrogen agonistic and antagonistic activities in immature female Sprague-Dawley rat model. The benzopyran derivatives 17 and 18

Induction of targeted osteogenesis with 3-aryl-2H-benzopyrans and 3-aryl-3H-benzopyrans: Novel osteogenic agents

Development of target oriented chemotherapeutics for treatment of chronic diseases have been considered as an important approach in drug development. Following this approach, in our efforts for exploration of new osteogenic leads, substituted 3-aryl-2H-be